Literature DB >> 32090696

Progressive supranuclear palsy and primary lateral sclerosis secondary to globular glial tauopathy: a case report and a practical theoretical framework for the clinical prediction of this rare pathological entity.

Andy J Liu1, Jessica E Chang2, Georges Naasan1, Adam L Boxer1, Bruce L Miller1, Salvatore Spina1.   

Abstract

Globular glial tauopathy (GGT) is a rare 4-repeat tauopathy characterized by the accumulation of tau globular inclusions in astrocytes and oligodendrocytes. Several clinical phenotypes have been associated with GGT, making the prediction of this rare pathological entity difficult. We report the case of a patient with eye-movement abnormalities and gait instability, reminiscent of progressive supranuclear palsy-Richardson's syndrome (PSP-RS), who later developed upper motor neuron symptoms suggestive of primary lateral sclerosis (PLS). Neuropathological assessment revealed GGT type III pathology. A theoretical framework is proposed to help clinicians predict GGT in subjects with coexistent features of PSP-RS and PLS.

Entities:  

Keywords:  Globular glial tauopathy; frontotemporal dementia; neuropathology; primary lateral sclerosis; progressive supranuclear palsy

Mesh:

Year:  2020        PMID: 32090696      PMCID: PMC7197509          DOI: 10.1080/13554794.2020.1732427

Source DB:  PubMed          Journal:  Neurocase        ISSN: 1355-4794            Impact factor:   0.881


  35 in total

1.  Sporadic four-repeat tauopathy with frontotemporal degeneration, parkinsonism and motor neuron disease.

Authors:  Yue-Shan Piao; Chun-Feng Tan; Keisuke Iwanaga; Akiyoshi Kakita; Hiroki Takano; Masatoyo Nishizawa; Tammaryn Lashley; Tamas Revesz; Andrew Lees; Rohan de Silva; Mitsuhiro Tsujihata; Hitoshi Takahashi
Journal:  Acta Neuropathol       Date:  2005-11-22       Impact factor: 17.088

2.  Globular Glial Mixed Four Repeat Tau and TDP-43 Proteinopathy with Motor Neuron Disease and Frontotemporal Dementia.

Authors:  Ryoko Takeuchi; Yasuko Toyoshima; Mari Tada; Hidetomo Tanaka; Hiroshi Shimizu; Atsushi Shiga; Takeshi Miura; Kenju Aoki; Akane Aikawa; Shin Ishizawa; Takeshi Ikeuchi; Masatoyo Nishizawa; Akiyoshi Kakita; Hitoshi Takahashi
Journal:  Brain Pathol       Date:  2015-05-19       Impact factor: 6.508

3.  Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.

Authors:  P Tacik; M Sanchez-Contreras; M DeTure; M E Murray; R Rademakers; O A Ross; Z K Wszolek; J E Parisi; D S Knopman; R C Petersen; D W Dickson
Journal:  Neuropathol Appl Neurobiol       Date:  2017-03-08       Impact factor: 8.090

Review 4.  Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.

Authors:  Gabor G Kovacs; Isidro Ferrer; Lea T Grinberg; Irina Alafuzoff; Johannes Attems; Herbert Budka; Nigel J Cairns; John F Crary; Charles Duyckaerts; Bernardino Ghetti; Glenda M Halliday; James W Ironside; Seth Love; Ian R Mackenzie; David G Munoz; Melissa E Murray; Peter T Nelson; Hitoshi Takahashi; John Q Trojanowski; Olaf Ansorge; Thomas Arzberger; Atik Baborie; Thomas G Beach; Kevin F Bieniek; Eileen H Bigio; Istvan Bodi; Brittany N Dugger; Mel Feany; Ellen Gelpi; Stephen M Gentleman; Giorgio Giaccone; Kimmo J Hatanpaa; Richard Heale; Patrick R Hof; Monika Hofer; Tibor Hortobágyi; Kurt Jellinger; Gregory A Jicha; Paul Ince; Julia Kofler; Enikö Kövari; Jillian J Kril; David M Mann; Radoslav Matej; Ann C McKee; Catriona McLean; Ivan Milenkovic; Thomas J Montine; Shigeo Murayama; Edward B Lee; Jasmin Rahimi; Roberta D Rodriguez; Annemieke Rozemüller; Julie A Schneider; Christian Schultz; William Seeley; Danielle Seilhean; Colin Smith; Fabrizio Tagliavini; Masaki Takao; Dietmar Rudolf Thal; Jon B Toledo; Markus Tolnay; Juan C Troncoso; Harry V Vinters; Serge Weis; Stephen B Wharton; Charles L White; Thomas Wisniewski; John M Woulfe; Masahito Yamada; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2015-12-10       Impact factor: 17.088

Review 5.  Frontotemporal dementia.

Authors:  Jee Bang; Salvatore Spina; Bruce L Miller
Journal:  Lancet       Date:  2015-10-24       Impact factor: 79.321

Review 6.  A clinical and neuropathological study of an unusual case of sporadic tauopathy. A variant of corticobasal degeneration?

Authors:  Shinji Ohara; Jun Tsuyuzaki; Takashi Oide; Hiroyuki Arai; Susumu Higuchi; Masato Hasegawa; Takeshi Iwatsubo
Journal:  Neurosci Lett       Date:  2002-09-13       Impact factor: 3.046

7.  A harmonized classification system for FTLD-TDP pathology.

Authors:  Ian R A Mackenzie; Manuela Neumann; Atik Baborie; Deepak M Sampathu; Daniel Du Plessis; Evelyn Jaros; Robert H Perry; John Q Trojanowski; David M A Mann; Virginia M Y Lee
Journal:  Acta Neuropathol       Date:  2011-06-05       Impact factor: 17.088

8.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

Authors:  Günter U Höglinger; Gesine Respondek; Maria Stamelou; Carolin Kurz; Keith A Josephs; Anthony E Lang; Brit Mollenhauer; Ulrich Müller; Christer Nilsson; Jennifer L Whitwell; Thomas Arzberger; Elisabet Englund; Ellen Gelpi; Armin Giese; David J Irwin; Wassilios G Meissner; Alexander Pantelyat; Alex Rajput; John C van Swieten; Claire Troakes; Angelo Antonini; Kailash P Bhatia; Yvette Bordelon; Yaroslau Compta; Jean-Christophe Corvol; Carlo Colosimo; Dennis W Dickson; Richard Dodel; Leslie Ferguson; Murray Grossman; Jan Kassubek; Florian Krismer; Johannes Levin; Stefan Lorenzl; Huw R Morris; Peter Nestor; Wolfgang H Oertel; Werner Poewe; Gil Rabinovici; James B Rowe; Gerard D Schellenberg; Klaus Seppi; Thilo van Eimeren; Gregor K Wenning; Adam L Boxer; Lawrence I Golbe; Irene Litvan
Journal:  Mov Disord       Date:  2017-05-03       Impact factor: 10.338

9.  Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report.

Authors:  Koji Fujita; Tomoyasu Matsubara; Ryosuke Miyamoto; Hiroyuki Sumikura; Toshiaki Takeuchi; Keiko Maruyama Saladini; Toshitaka Kawarai; Hiroyuki Nodera; Fukashi Udaka; Kodai Kume; Hiroyuki Morino; Hideshi Kawakami; Masato Hasegawa; Ryuji Kaji; Shigeo Murayama; Yuishin Izumi
Journal:  BMC Neurol       Date:  2019-07-18       Impact factor: 2.474

10.  Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies.

Authors:  Zeshan Ahmed; Karen M Doherty; Laura Silveira-Moriyama; Rina Bandopadhyay; Tammaryn Lashley; Adamantios Mamais; Geshanthi Hondhamuni; Selina Wray; Jia Newcombe; Sean S O'Sullivan; Stephen Wroe; Rohan de Silva; Janice L Holton; Andrew J Lees; Tamas Revesz
Journal:  Acta Neuropathol       Date:  2011-07-21       Impact factor: 17.088

View more
  5 in total

1.  Corpus callosum hypersignals and focal atrophy: Neuroimaging findings in globular glial tauopathy type I.

Authors:  Jiri Keller; Anna Kavkova; Radoslav Matej; Zsolt Cséfalvay; Robert Rusina
Journal:  Eur J Neurol       Date:  2021-09-12       Impact factor: 6.288

2.  Parkinsonian Syndromes in Motor Neuron Disease: A Clinical Study.

Authors:  Jacopo Pasquini; Francesca Trogu; Claudia Morelli; Barbara Poletti; Floriano Girotti; Silvia Peverelli; Alberto Brusati; Antonia Ratti; Andrea Ciammola; Vincenzo Silani; Nicola Ticozzi
Journal:  Front Aging Neurosci       Date:  2022-06-27       Impact factor: 5.702

Review 3.  Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies.

Authors:  Maria Stamelou; Gesine Respondek; Nikolaos Giagkou; Jennifer L Whitwell; Gabor G Kovacs; Günter U Höglinger
Journal:  Nat Rev Neurol       Date:  2021-08-23       Impact factor: 42.937

Review 4.  Clinical Spectrum of Tauopathies.

Authors:  Nahid Olfati; Ali Shoeibi; Irene Litvan
Journal:  Front Neurol       Date:  2022-07-14       Impact factor: 4.086

Review 5.  Neuroimaging in Frontotemporal Dementia: Heterogeneity and Relationships with Underlying Neuropathology.

Authors:  Bradley T Peet; Salvatore Spina; Nidhi Mundada; Renaud La Joie
Journal:  Neurotherapeutics       Date:  2021-08-13       Impact factor: 7.620

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.